The most well-known CRL2 substrate recognition receptor is the tumor suppressor protein VHL that is mutated in von Hippel–Lindau (VHL) syndrome, a rare hereditary cancer syndrome [5]. The gene discussed is VHL; the disease is von Hippel-Lindau disease.